Skip to main content
. 2017 May 17;19(Suppl 1):44–54. doi: 10.22074/cellj.2017.4412

Fig.4.

Fig.4

Metabolic pathway map of humans that show some of the affected metabolites in non-Hodgkin’s lymphoma (NHL) and myeloma patients.